Author

Harriet Namata

Observed names: H Namata, NAMATA, Harriet, Namata, H

Institutions: National University of Singapore, MRC Clinical Trials Unit at UCL, University College London, Medical Research Council

Observed institutions: National University of Singapore, MRC Clinical Trials Unit at UCL, World Health Organization, Infectious Diseases Institute, World Health Organization - Uganda, Joint Clinical Research Centre, University College London, Makerere University, Hasselt University, Medical Research Council

OpenAlex ID: A5061752010

Salmonella in Belgian laying hens: An identification of risk factors

2007 · Harriet Namata, Estelle Méroc, et al. · Preventive Veterinary Medicine · 99

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

2017 · Nicholas I Paton, Nicholas I Paton, et al. · The Lancet HIV · 80

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

2018 · Seth C Inzaule, Raph L Hamers, et al. · The Lancet HIV · 78

Identification of risk factors for the prevalence and persistence of Salmonella in Belgian broiler chicken flocks

2009 · Harriet Namata, Sarah Welby, et al. · Preventive Veterinary Medicine · 61

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

2017 · James G Hakim, Jennifer Thompson, et al. · The Lancet Infectious Diseases · 41

The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

2014 · Adrienne K Chan, Deborah Ford, et al. · BMC Health Services Research · 33

Model Averaging in Microbial Risk Assessment Using Fractional Polynomials

2008 · Harriet Namata, Marc Aerts, et al. · Risk Analysis · 29

Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study

2016 · the Lablite team, Misheck J. Nkhata, et al. · BMC Health Services Research · 12

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

2018 · Jennifer A Thompson, Cissy Kityo, et al. · Clinical Infectious Diseases · 11

Estimation of the Force of Infection from Current Status Data Using Generalized Linear Mixed Models

2007 · Harriet Namata, Ziv Shkedy, et al. · Journal of Applied Statistics · 7

Lablite: baseline mapping survey of decentralised ART service provision in Malawi, Uganda and Zimbabwe.

2012 · George Abongomera, Harriet Namata, et al. · 4

Shifting Human Resources for Health in the context of ART provision in primary care facilities: qualitative and quantitative findings from the Lablite Baseline Survey

2013 · Misheck J. Nkhata, Fabian Cataldo, et al.

Flexible statistical models for microbial risk assessment and infectious diseases

2008 · NAMATA, Harriet · Document Server@UHasselt (UHasselt)

Model averaging in microbial risk asssessment using fractional polynomials

2008 · Namata, H, Aerts, M, et al. · Rivm Repository (Netherlands National Institute for Public Health and the Environment)

Works count: 15

Citation count: 455

H-index: 9

I10-index: 9